DR REDDYS LABORATORIES
|
DR REDDYS LABORATORIES Last 5 Year Balance Sheet History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
EQUITY AND LIABILITIES | |||||
Share Capital | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
Equity - Authorised | ₹145 Cr | ₹145 Cr | ₹120 Cr | ₹120 Cr | ₹120 Cr |
Equity - Issued | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
Equity Paid Up | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr | ₹83 Cr |
Equity Shares Forfeited | - | - | - | - | - |
Adjustments to Equity | - | - | - | - | - |
Preference Capital Paid Up | - | - | - | - | - |
Face Value | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 | ₹5.00 |
Share Warrants & Outstandings | ₹131 Cr | ₹146 Cr | ₹143 Cr | ₹127 Cr | ₹104 Cr |
Total Reserves | ₹28,040 Cr | ₹23,057 Cr | ₹18,986 Cr | ₹17,432 Cr | ₹15,412 Cr |
Securities Premium | ₹819 Cr | ₹711 Cr | ₹670 Cr | ₹631 Cr | ₹592 Cr |
Capital Reserves | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr | ₹27 Cr |
Profit & Loss Account Balance | ₹24,998 Cr | ₹20,023 Cr | ₹16,034 Cr | ₹14,240 Cr | ₹12,835 Cr |
General Reserves | ₹2,037 Cr | ₹2,037 Cr | ₹2,037 Cr | ₹2,037 Cr | ₹2,037 Cr |
Other Reserves | ₹159 Cr | ₹259 Cr | ₹218 Cr | ₹498 Cr | ₹-79 Cr |
Reserve excluding Revaluation Reserve | ₹28,040 Cr | ₹23,057 Cr | ₹18,986 Cr | ₹17,432 Cr | ₹15,412 Cr |
Revaluation reserve | - | - | - | - | - |
Shareholder's Funds | ₹28,255 Cr | ₹23,286 Cr | ₹19,212 Cr | ₹17,642 Cr | ₹15,599 Cr |
Minority Interest | - | - | - | - | - |
Long-Term Borrowings | - | - | - | - | - |
Secured Loans | ₹219 Cr | ₹128 Cr | ₹195 Cr | ₹250 Cr | ₹130 Cr |
Non Convertible Debentures | - | - | - | - | - |
Converible Debentures & Bonds | - | - | - | - | - |
Packing Credit - Bank | - | - | - | - | - |
Inter Corporate & Security Deposit | - | - | - | - | - |
Term Loans - Banks | - | - | - | - | - |
Term Loans - Institutions | - | - | - | - | - |
Other Secured | ₹219 Cr | ₹128 Cr | ₹195 Cr | ₹250 Cr | ₹130 Cr |
Unsecured Loans | ₹380 Cr | - | ₹380 Cr | ₹380 Cr | - |
Fixed Deposits - Public | - | - | - | - | - |
Loans and advances from subsidiaries | - | - | - | - | - |
Inter Corporate Deposits (Unsecured) | - | - | - | - | - |
Foreign Currency Convertible Notes | - | - | - | - | - |
Long Term Loan in Foreign Currency | - | - | - | - | - |
Loans - Banks | ₹380 Cr | - | - | - | - |
Loans - Govt. | - | - | - | - | - |
Loans - Others | - | - | - | - | - |
Other Unsecured Loan | - | - | ₹380 Cr | ₹380 Cr | - |
Deferred Tax Assets / Liabilities | ₹-974 Cr | ₹-629 Cr | ₹-1,276 Cr | ₹-1,040 Cr | ₹-1,218 Cr |
Deferred Tax Assets | ₹1,445 Cr | ₹999 Cr | ₹1,630 Cr | ₹1,343 Cr | ₹1,482 Cr |
Deferred Tax Liability | ₹471 Cr | ₹370 Cr | ₹354 Cr | ₹303 Cr | ₹264 Cr |
Other Long Term Liabilities | ₹314 Cr | ₹203 Cr | ₹167 Cr | ₹162 Cr | ₹206 Cr |
Long Term Trade Payables | - | - | - | - | - |
Long Term Provisions | ₹24 Cr | ₹20 Cr | ₹26 Cr | ₹51 Cr | ₹75 Cr |
Total Non-Current Liabilities | ₹-37 Cr | ₹-278 Cr | ₹-508 Cr | ₹-197 Cr | ₹-808 Cr |
Current Liabilities | - | - | - | - | - |
Trade Payables | ₹2,614 Cr | ₹2,268 Cr | ₹2,266 Cr | ₹1,811 Cr | ₹1,525 Cr |
Sundry Creditors | ₹2,614 Cr | ₹2,268 Cr | ₹2,266 Cr | ₹1,811 Cr | ₹1,525 Cr |
Acceptances | - | - | - | - | - |
Due to Subsidiaries- Trade Payables | - | - | - | - | - |
Other Current Liabilities | ₹4,775 Cr | ₹4,698 Cr | ₹3,661 Cr | ₹3,338 Cr | ₹3,512 Cr |
Bank Overdraft / Short term credit | - | - | - | - | - |
Advances received from customers | ₹106 Cr | ₹117 Cr | ₹134 Cr | ₹98 Cr | ₹67 Cr |
Interest Accrued But Not Due | ₹6.20 Cr | ₹13 Cr | ₹13 Cr | ₹9.40 Cr | ₹3.00 Cr |
Share Application Money | - | - | - | - | - |
Current maturity of Debentures & Bonds | - | ₹380 Cr | - | - | ₹378 Cr |
Current maturity - Others | ₹131 Cr | ₹100 Cr | ₹102 Cr | ₹86 Cr | ₹48 Cr |
Other Liabilities | ₹4,532 Cr | ₹4,088 Cr | ₹3,412 Cr | ₹3,144 Cr | ₹3,016 Cr |
Short Term Borrowings | ₹1,272 Cr | ₹739 Cr | ₹2,708 Cr | ₹2,315 Cr | ₹1,653 Cr |
Secured ST Loans repayable on Demands | - | - | - | - | - |
Working Capital Loans- Sec | - | - | - | - | - |
Buyers Credits - Unsec | - | - | - | - | - |
Commercial Borrowings- Unsec | - | - | - | - | - |
Other Unsecured Loans | ₹1,272 Cr | ₹739 Cr | ₹2,708 Cr | ₹2,315 Cr | ₹1,653 Cr |
Short Term Provisions | ₹926 Cr | ₹867 Cr | ₹1,131 Cr | ₹640 Cr | ₹524 Cr |
Proposed Equity Dividend | - | - | - | - | - |
Provision for Corporate Dividend Tax | - | - | - | - | - |
Provision for Tax | ₹234 Cr | ₹214 Cr | ₹544 Cr | ₹139 Cr | ₹57 Cr |
Provision for post retirement benefits | - | - | - | - | - |
Preference Dividend | - | - | - | - | - |
Other Provisions | ₹692 Cr | ₹653 Cr | ₹587 Cr | ₹502 Cr | ₹467 Cr |
Total Current Liabilities | ₹9,588 Cr | ₹8,572 Cr | ₹9,766 Cr | ₹8,104 Cr | ₹7,214 Cr |
Total Liabilities | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr | ₹22,005 Cr |
ASSETS | |||||
Gross Block | ₹28,062 Cr | ₹25,567 Cr | ₹23,096 Cr | ₹21,887 Cr | ₹19,336 Cr |
Less: Accumulated Depreciation | ₹17,636 Cr | ₹16,348 Cr | ₹14,895 Cr | ₹13,632 Cr | ₹12,485 Cr |
Less: Impairment of Assets | ₹0.50 Cr | - | ₹80 Cr | ₹49 Cr | - |
Net Block | ₹10,426 Cr | ₹9,219 Cr | ₹8,122 Cr | ₹8,206 Cr | ₹6,850 Cr |
Lease Adjustment A/c | - | - | - | - | - |
Capital Work in Progress | ₹1,351 Cr | ₹975 Cr | ₹1,280 Cr | ₹954 Cr | ₹436 Cr |
Non Current Investments | ₹542 Cr | ₹646 Cr | ₹593 Cr | ₹833 Cr | ₹309 Cr |
Long Term Investment | ₹542 Cr | ₹646 Cr | ₹593 Cr | ₹833 Cr | ₹309 Cr |
Quoted | ₹38 Cr | ₹35 Cr | ₹120 Cr | ₹453 Cr | ₹30 Cr |
Unquoted | ₹504 Cr | ₹611 Cr | ₹473 Cr | ₹380 Cr | ₹279 Cr |
Long Term Loans & Advances | ₹542 Cr | ₹356 Cr | ₹452 Cr | ₹377 Cr | ₹689 Cr |
Other Non Current Assets | ₹89 Cr | ₹13 Cr | ₹222 Cr | ₹17 Cr | ₹23 Cr |
Total Non-Current Assets | ₹13,017 Cr | ₹11,264 Cr | ₹10,682 Cr | ₹10,998 Cr | ₹9,406 Cr |
Current Assets Loans & Advances | - | - | - | - | - |
Currents Investments | ₹4,388 Cr | ₹4,340 Cr | ₹2,023 Cr | ₹1,379 Cr | ₹2,369 Cr |
Quoted | - | - | - | - | - |
Unquoted | ₹4,388 Cr | ₹4,340 Cr | ₹2,023 Cr | ₹1,379 Cr | ₹2,369 Cr |
Inventories | ₹6,355 Cr | ₹4,867 Cr | ₹5,088 Cr | ₹4,541 Cr | ₹3,507 Cr |
Raw Materials | ₹1,861 Cr | ₹1,186 Cr | ₹1,358 Cr | ₹1,215 Cr | ₹1,039 Cr |
Work-in Progress | ₹1,422 Cr | ₹1,170 Cr | ₹1,289 Cr | ₹1,001 Cr | ₹681 Cr |
Finished Goods | ₹1,987 Cr | ₹1,362 Cr | ₹1,387 Cr | ₹1,373 Cr | ₹825 Cr |
Packing Materials | - | - | - | - | - |
Stores  and Spare | ₹505 Cr | ₹393 Cr | ₹380 Cr | ₹329 Cr | ₹254 Cr |
Other Inventory | ₹581 Cr | ₹757 Cr | ₹676 Cr | ₹624 Cr | ₹708 Cr |
Sundry Debtors | ₹8,030 Cr | ₹7,249 Cr | ₹6,676 Cr | ₹4,964 Cr | ₹5,028 Cr |
Debtors more than Six months | ₹469 Cr | ₹281 Cr | ₹178 Cr | ₹111 Cr | ₹105 Cr |
Debtors Others | ₹7,706 Cr | ₹7,094 Cr | ₹6,618 Cr | ₹4,983 Cr | ₹5,043 Cr |
Cash and Bank | ₹1,728 Cr | ₹1,730 Cr | ₹2,419 Cr | ₹2,079 Cr | ₹205 Cr |
Cash in hand | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.10 Cr | ₹0.20 Cr |
Balances at Bank | ₹1,728 Cr | ₹1,730 Cr | ₹2,419 Cr | ₹2,079 Cr | ₹205 Cr |
Other cash and bank balances | - | - | - | - | - |
Other Current Assets | ₹1,060 Cr | ₹1,204 Cr | ₹737 Cr | ₹850 Cr | ₹1,046 Cr |
Interest accrued on Investments | - | - | - | - | - |
Interest accrued on Debentures | - | - | - | - | - |
Deposits with Government | - | - | - | - | - |
Interest accrued and or due on loans | - | - | - | - | - |
Prepaid Expenses | ₹195 Cr | ₹145 Cr | ₹114 Cr | ₹114 Cr | ₹95 Cr |
Other current_assets | ₹865 Cr | ₹1,058 Cr | ₹623 Cr | ₹736 Cr | ₹951 Cr |
Short Term Loans and Advances | ₹3,228 Cr | ₹927 Cr | ₹844 Cr | ₹723 Cr | ₹445 Cr |
Advances recoverable in cash or in kind | ₹13 Cr | ₹28 Cr | ₹15 Cr | ₹16 Cr | ₹11 Cr |
Advance income tax and TDS | - | - | - | - | - |
Amounts due from directors | - | - | - | - | - |
Due From Subsidiaries | - | - | - | - | - |
Inter corporate deposits | - | - | - | - | - |
Corporate Deposits | - | - | - | - | - |
Other Loans & Advances | ₹3,215 Cr | ₹899 Cr | ₹830 Cr | ₹707 Cr | ₹433 Cr |
Total Current Assets | ₹24,789 Cr | ₹20,316 Cr | ₹17,788 Cr | ₹14,535 Cr | ₹12,599 Cr |
Net Current Assets (Including Current Investments) | ₹15,201 Cr | ₹11,744 Cr | ₹8,022 Cr | ₹6,431 Cr | ₹5,385 Cr |
Miscellaneous Expenses not written off | - | - | - | - | - |
Total Assets | ₹37,806 Cr | ₹31,580 Cr | ₹28,470 Cr | ₹25,548 Cr | ₹22,005 Cr |
Contingent Liabilities | ₹107 Cr | ₹107 Cr | ₹108 Cr | ₹96 Cr | ₹177 Cr |
Total Debt | ₹2,002 Cr | ₹1,347 Cr | ₹3,385 Cr | ₹3,031 Cr | ₹2,210 Cr |
Book Value | - | 1,388.98 | 1,145.98 | 1,052.59 | 932.31 |
Adjusted Book Value | 1,686.06 | 1,388.98 | 1,145.98 | 1,052.59 | 932.31 |
Compare Balance Sheet of peers of DR REDDYS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DR REDDYS LABORATORIES | ₹110,746.5 Cr | -1.8% | -2.2% | 20.6% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹457,025.0 Cr | -2% | 4.3% | 65.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,952.0 Cr | -0.5% | 6.4% | 44.2% | Stock Analytics | |
CIPLA | ₹131,056.0 Cr | -2.9% | -1.8% | 39.5% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹105,745.0 Cr | -1.6% | -6.3% | 73.8% | Stock Analytics | |
MANKIND PHARMA | ₹102,507.0 Cr | 0.7% | 8.1% | 41.1% | Stock Analytics |
DR REDDYS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DR REDDYS LABORATORIES | -1.8% |
-2.2% |
20.6% |
SENSEX | -5.3% |
-1.6% |
23.1% |
You may also like the below Video Courses